JPRN-UMIN000000519Completed未知
A prospective study:the clinical value of acidosis correction by acetate free biofiltration (AFB) in hemodialysis patients. - A prospective study:the clinical value of acidosis correction by acetate free biofiltration (AFB) in hemodialysis patients.
Showa University of Medicine Department of Nephrology0 sites30 target enrollmentStarted: November 30, 2006Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1)chronic inflammation, malignant disorder, severe respiratory organs and liver disorder, heart failure (2)20 years or older. (3)participating in another clinical trial for 12 weeks or longer. (4)pregnant, during the nursing, possibly pregnant and having the hope of child bearing. (5)judged inappropriate as study subject by the investigator.
Investigators
Similar Trials
Completed
Not Applicable
Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosapatients on hemodialysisJPRN-UMIN000038929Osaka medical college42
Active, not recruiting
Phase 1
The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass (Protocol No. P05633): RED-CABG Trial (Reduction in Cardiovascular Events by Acadesine in Subjects Undergoing CABG) - RED-CABG TrialCoronary artery diseaseMedDRA version: 9.1 Level: LLT Classification code 10011078 Term: Coronary artery diseaseEUCTR2008-004881-16-DESchering-Plough Research Institute, a Division of Schering Corporation7,500
Active, not recruiting
Phase 1
The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass: RED-CABG Trial (Reduction in Cardiovascular Events by Acadesine in Subjects Undergoing CABG). - RED CABG TrialCoronary artery diseaseMedDRA version: 9.1 Level: LLT Classification code 10011078 Term: Coronary artery diseaseEUCTR2008-004881-16-ITSchering-Plough Research Institute, a Division of Schering Corporation7,500
Active, not recruiting
Phase 1
The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass (Protocol No. P05633): RED-CABG Trial (Reduction in Cardiovascular Events by Acadesine in Subjects Undergoing CABG) - RED-CABG TrialEUCTR2008-004881-16-FRSchering-Plough Research Institute, a Division of Schering Corporation7,500
Recruiting
Not Applicable
Clinical evaluation of Ozone gas efficiency on Tooth sensitivity and Tooth whiteningRBR-6685wtniversidade Estadual do Oeste do Paraná - UNIOESTE